Former PPL director Colman joins ES Cell
05 March, 2002 by Tanya HollisEmbryonic stem cell researcher ES Cell International (ESI) has announced five senior management positions as it gears up for its development phase.
Vics look overseas to fill top job
05 March, 2002 by Tanya HollisOffshore candidates are likely to be prime contenders for the Victorian Government's newly created position of director of biotechnology.
Industry group has new Canberra presence
05 March, 2002 by Iain ScottThe new executive director of the Scientific Industry Association (SIA) says being based in Canberra will help the organisation to have a stronger voice.
NZ will lose to Australia: bioentrepreneur
05 March, 2002 by Tanya HollisA prominent New Zealand entrepreneur has warned that financial institutions needed to take a punt on the emerging sector or risk losing business to Australia.
Peptech seeking new CEO
05 March, 2002 by Iain ScottSydney biotech Peptech is on the hunt for a new CEO.
Tougher patent process aims to increase innovation
01 March, 2002 by Daniella GoldbergChanges to Australian patent laws from April 1 will make filing harder, but will also bring the country more into line with US and European patent laws.
All smiles as SDI reports profit jump
28 February, 2002 by Tanya HollisDental research group SDI has reported a half-yearly jump in profits and sales on the back of its suite of aesthetic and alloy restorative products.
Australian researchers wasting IP, warns patent expert
28 February, 2002 by Tanya HollisAustralian researchers were wasting 90 per cent of their intellectual property value because they did not understand how to use it, a patent attorney has warned.
WA biotech mines double benefit from listing vehicle
27 February, 2002 by Pete YoungBacking hopeful young companies into the listed shells of mining companies is an old habit in Western Australia.
Australian biotechs must merge or perish: Ernst and Young
27 February, 2002 by Tanya HollisAustralia's biotechnology companies will have to merge or perish, according to leading industry analyst Ernst and Young.
Xenome chief flags industry insurance fears
27 February, 2002 by Pete YoungThere are fears the current insurance industry upheaval will force some biotechs to the wall unless the Gene Technology Act 2000 is overhauled.
CSIRO lifting its game: Garrett
26 February, 2002 by Tanya HollisCSIRO was well on its way to addressing the raft of serious problems outlined in a confidential internal report, the organisation's chief has claimed.
Cone snail proving to be companies' best friend
26 February, 2002 by Melissa TrudingerThe cone snail, a marine snail from the Great Barrier Reef, is proving to be a vaulable ally in pain management drug research.
Consolidation contributes to Agenix half-year profit
26 February, 2002 by Daniella GoldbergAgenix Limited (ASX: AGH) has announced a 435 per cent increase in after-tax profit to $1.7 million for the six months to December 31, 2001.
Go west, young biotech entrepreneur
25 February, 2002 by Daniella GoldbergBioWest, the first directory for the biotechnology industry in western Sydney, is being launched today by Kim Yeadon, NSW Minister for Western Sydney.
